封面
市场调查报告书
商品编码
1741140

数位治疗 (DTx) 市场:按应用、产品类型、销售管道/BtoC 和地区

Digital Therapeutics Market, By Application, By Product Type (Software and Device), By Sales Channel and Business-to-Consumer (B2C) (Patient and Caregiver), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

出版日期: | 出版商: Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3个工作天内

价格
简介目录

数位治疗 (DTx) 市场规模在 2025 年估计为 115.4 亿美元,预计到 2032 年将达到 425.7 亿美元,2025 年至 2032 年的年复合成长率(CAGR)为 20.5%。

报告范围 报告详细信息
基准年 2024 2025年的市场规模 115.4亿美元
效能数据 从2020年到2024年 预测期 2025年至2032年
预测期:2025-2032年复合年增长率: 20.50% 2032年价值预测 425.7亿美元

数位治疗 (DTx) 是基于软体的实证治疗性介入,用于预防、管理和治疗医疗状况和疾病。数位治疗 (DTx) 是数位医疗保健的一部分,它透过循证且经过临床评估的疾病管理软体直接向患者提供治疗性介入。

市场动态:

慢性病负担加重、COVID-19(大流行)爆发、以患者为中心的医疗保健应用程式的采用率不断提高、数位医疗保健解决方案和技术的采用率不断提高以及政府对预防性医疗保健的日益重视,是预计将促进全球数位治疗 (DTx) 市场成长的关键因素。

例如,2022 年 2 月,DynamiCare Health Inc. 宣布处方笺专用数位疗法 (DTx) DCH-001 已获得美国食品药物管理局(FDA) 的突破性设备称号,用于治疗与怀孕和分娩共存的烟草使用障碍。

此外,AmerisourceBergen计划于2022年7月推出数位治疗 (DTx) 平台,以更方便地获取创新产品。该平台将使医生能够透过电子处方工作流程轻鬆取得和订购处方和非处方数位治疗 (DTx),并监控患者对数位治疗 (DTx) 和诊断的履行。

本研究的主要特点

  • 本报告对全球数位治疗 (DTx) 市场进行了详细分析,并以 2024 年为基准年,提供了预测期 2025-2032 的市场规模和年复合成长率(CAGR%)。
  • 它还强调了各个领域的潜在商机,并说明了该市场的有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
  • 全球数位治疗 (DTx) 市场的主要企业根据以下参数进行分析,例如公司亮点、产品系列、关键亮点、财务表现和策略。
  • 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
  • 全球数位治疗 (DTx) 市场报告迎合了该行业的各个相关人员,包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
  • 可以透过用于分析全球数位治疗 (DTx) 市场的各种策略矩阵来促进相关人员的决策。

目录

第一章 调查目的与前提条件

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告描述
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规与趋势分析

  • 市场动态
    • 全球慢性病负担日益加重
    • 病患资料隐私问题
    • 扩大数位治疗 (DTx) 的应用
  • 影响分析
  • 主要亮点
  • 监管情景
  • 产品发布/核准
  • PEST分析
  • 波特分析
  • 併购场景

4. 全球数位治疗 (DTx) 市场 - 冠状病毒 (COVID-19) 大流行的影响

  • COVID-19流行病学
  • 供需侧分析
  • 经济影响

5. 全球数位治疗 (DTx) 市场(按应用划分),2020 年至 2032 年

  • 糖尿病
  • 肥胖
  • 心血管疾病(CVD)
  • 中枢神经系统 (CNS) 疾病
  • 呼吸系统疾病
  • 禁止抽烟
  • 胃肠道疾病(GID)
  • 其他的

6. 2020 年至 2032 年全球数位治疗 (DTx) 市场(依产品类型)

  • 软体
  • 装置

7. 全球数位治疗 (DTx) 市场依销售管道,2020-2032 年

  • 企业对企业(B2B)
  • 雇主
  • 医疗保健提供者
  • 其他的
  • 企业对消费者(B2C)
  • 病人
  • 看护者

8. 2020 年至 2032 年全球数位治疗 (DTx) 市场(按地区)

  • 北美洲
  • 拉丁美洲
  • 欧洲
  • 亚太地区
  • 中东
  • 非洲

第九章 竞争态势

  • Happify, Inc.
  • 2Morrow, Inc.
  • Akili Interactive Labs, Inc.
  • Click Therapeutics, Inc.
  • Fitbit, Inc.(Twine Health, Inc.)

第 10 章 章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5865

Digital Therapeutics Market is estimated to be valued at USD 11.54 Bn in 2025 and is expected to reach USD 42.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 20.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 11.54 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 20.50% 2032 Value Projection: USD 42.57 Bn

Digital Therapeutics (DTx) are evidence-based therapeutic interventions driven by the software to prevent, manage, or treat a medical disorder or disease. Digital Therapeutics are a part of the digital healthcare that deliver therapeutic interventions directly to patients via evidence-based, clinically-evaluated software for disease management.

Market Dynamics:

Increasing burden of chronic diseases, the outbreak of COVID-19 (pandemic), increasing adoption of patient-centric healthcare apps, growing adoption of digital healthcare solutions or technologies, and increasing focus toward preventive healthcare by governments are major factors expected to augment the growth of the global digital therapeutics market.

For instance, in February 2022, DynamiCare Health Inc. announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for the DCH-001, a prescription-only digital therapeutic to treat tobacco use disorder complicating pregnancy and childbirth.

Moreover, in July 2022, AmerisourceBergen planned to launch digital therapeutics (DTx) platform to facilitate access to innovative products. The platform enables doctors to easily access and order prescription and non-prescription DTx through their e-prescribing workflow and monitor patient fulfilment of digital therapeutics and diagnostics.

Key features of the study:

  • This report provides in-depth analysis of the global digital therapeutics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global digital therapeutics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Happify, Inc., 2Morrow, Inc., Akili Interactive Labs, Inc., Click Therapeutics, Inc., and Fitbit, Inc. (Twine Health, Inc.).
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global digital therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital therapeutics market.

Detailed Segmentation:

  • Global Digital Therapeutics Market, By Application:
    • Diabetes
    • Obesity
    • Cardiovascular Disease (CVD)
    • Central Nervous System (CNS) Disease
    • Respiratory Disease
    • Smoking Cessation
    • Gastrointestinal Disorder (GID)
    • Others
  • Global Digital Therapeutics Market, By Product Type:
    • Software
    • Device
  • Global Digital Therapeutics Market, By Sales Channel:
    • Business-to-Business (B2B)
    • Employer
    • Healthcare Provider
    • Others
    • Business-to-Consumer (B2C)
    • Patient
    • Caregiver
  • Global Digital Therapeutics Market, By Geography:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • Happify, Inc.
    • 2Morrow, Inc.
    • Akili Interactive Labs, Inc.
    • Click Therapeutics, Inc.
    • Fitbit, Inc. (Twine Health, Inc.)

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Application
    • Market Snapshot, By Product Type
    • Market Snapshot, By Sales Channel
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in burden of chronic diseases around the world
    • Concerns about patient data privacy
    • Increasing adoption of digital therapeutics (DTx)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Digital Therapeutics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Digital Therapeutics Market, By Application, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Obesity
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Cardiovascular Disease (CVD)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Central Nervous System (CNS) Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Respiratory Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Smoking Cessation
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Gastrointestinal Disorder (GID)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Digital Therapeutics Market, By Product Type, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Device
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Digital Therapeutics Market, By Sales Channel, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • Business-to-Business (B2B)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Employer
  • Healthcare Provider
  • Others
  • Business-to-Consumer (B2C)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
  • Patient
  • Caregiver

8. Global Digital Therapeutics Market, By Region, 2020-2032, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021-2032
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2020-2032,(US$ Bn)

9. Competitive Landscape

  • Happify, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • 2Morrow, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Akili Interactive Labs, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Click Therapeutics, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fitbit, Inc. (Twine Health, Inc.)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

10. Section

  • Research Methodology
  • About us